Intravenous immunoglobulin (IGIV)

intravenous immunoglobulin · Grifols Biologicals, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intravenous immunoglobulin (IGIV), covering 2017-05-05 to 2017-05-05. Get the full timeline:

Most recent: Clinical Trial Update: IGIV Study for Chronic ITP Patients Ages 3-70 [Phase 3]